The Valley Desk

NCT03734991 · Interventional trial

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

Overall registry status Completed

Phase 3

Conditions Candida Vulvovaginitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov